Cyclooxygenase isozymes and their gene structures and expression

被引:362
作者
Tanabe, T [1 ]
Tohnai, N [1 ]
机构
[1] Natl Cardiovasc Ctr, Inst Res, Dept Pharmacol, Suita, Osaka 5658565, Japan
来源
PROSTAGLANDINS & OTHER LIPID MEDIATORS | 2002年 / 68-9卷
关键词
cyclooxygenase; isozyme; signaling pathways;
D O I
10.1016/S0090-6980(02)00024-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The cyclooxygenase (COX, prostaglandin endoperoxide synthase) is a key enzyme in prostaglandin biosynthesis. Two isoforms of COX, COX-1 and COX-2, have been identified by molecular biological methods. The amino acid sequence homology between COX-1 and COX-2 is about 60% for the human enzymes. COX-1 is constitutively expressed in most tissues and cells in animal species. The COX-1 promoter region lacks a canonical TATA or CAAT box and is GC-rich. These features are consistent with those of a housekeeping gene. On the other hand, COX-2 is an inducible enzyme and is induced by various cytokines and mitogenic factors. The induction of COX-2 is suppressed by dexamethasone and PGJ(2). There are many consensus cis-elements in the 5'-flanking region to regulate the expression of COX-2. Among them, a CRE, an NF-kappaB site, a NF-IL6 motif and an E-box, regulate transcription independently or synergistically. Most of the transcriptional signaling pathways require activation of the mitogen-activated protein kinase (MAPK) cascade. Moreover, MAPK signaling pathways are involved in regulating COX-2 gene expression at the post-transcriptional level. (C) 2002 Published by Elsevier Science Inc.
引用
收藏
页码:95 / 114
页数:20
相关论文
共 120 条
[1]   Cyclooxygenase-2 inhibitor NS-398 protects neuronal cultures from lipopolysaccharide-induced neurotoxicity [J].
Araki, E ;
Forster, C ;
Dubinsky, JM ;
Ross, ME ;
Iadecola, C .
STROKE, 2001, 32 (10) :2370-2375
[2]   Prostaglandin G/H synthase-2 is the constitutive and dominant isoform in cultured human lung epithelial cells [J].
Asano, K ;
Lilly, CM ;
Drazen, JM .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 1996, 271 (01) :L126-L131
[3]   IMMUNOSUPPRESSION BY GLUCOCORTICOIDS - INHIBITION OF NF-KAPPA-B ACTIVITY THROUGH INDUCTION OF I-KAPPA-B SYNTHESIS [J].
AUPHAN, N ;
DIDONATO, JA ;
ROSETTE, C ;
HELMBERG, A ;
KARIN, M .
SCIENCE, 1995, 270 (5234) :286-290
[4]   NF-kappa B: Ten years after [J].
Baeuerle, PA ;
Baltimore, D .
CELL, 1996, 87 (01) :13-20
[5]   The NF-kappa B and I kappa B proteins: New discoveries and insights [J].
Baldwin, AS .
ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 :649-683
[6]   Expression and regulation of cyclooxygenase-2 in rat microglia [J].
Bauer, MKA ;
Lieb, K ;
SchulzeOsthoff, K ;
Berger, M ;
GebickeHaerter, PJ ;
Bauer, J ;
Fiebich, BL .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 243 (03) :726-731
[7]   Control of transcription by steroid hormones [J].
Beato, M ;
Truss, M ;
Chavez, S .
BASIS FOR CANCER MANAGEMENT, 1996, 784 :93-123
[8]   Enhanced bradykinin-stimulated prostaglandin release in the acutely inflamed guinea pig gallbladder is due to new synthesis of cyclooxygenase 1 and prostacyclin synthase [J].
Bogar, LJ ;
Bartula, LL ;
Parkman, HP ;
Myers, SI .
JOURNAL OF SURGICAL RESEARCH, 1999, 84 (01) :71-76
[9]   THE PATHOGENESIS OF SEPSIS [J].
BONE, RC .
ANNALS OF INTERNAL MEDICINE, 1991, 115 (06) :457-469
[10]   Vascular endothelial growth factor upregulates constitutive cyclooxygenase 1 in primary bovine and human endothelial cells [J].
Bryant, CE ;
Appleton, I ;
Mitchell, JA .
LIFE SCIENCES, 1998, 62 (24) :2195-2201